People can use cannabis by smoking it, vaping it or eating it in food
It may be effective at fighting colon, breast, lung, prostate and stomach cancer
KEY OBSERVATIONS Phone support at (909) 787-2342 is available six days a week
Adverse effects observed in trials to date include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (common with GLP-1 receptor agonists) Reduced appetite and weight loss , which may be excessive in some individuals Elevated heart rate , a concern noted with glucagon receptor agonism As with other incretin-based therapies, there is also a class-level signal for acute pancreatitis and gallbladder disease (including cholelithiasis and cholecystitis)
There is also concern about the potential for excessive or rapid weight loss when combining treatments, which may increase the risk of nutritional deficiencies, particularly in protein, vitamins, and minerals